[Illustrations de Arlequin] / Tristano Martinelli, aut. du texte

Comprend : [Fig. p. de titre : Arlequin ou] Arlechin. [Cote : microfilm R 26976] ; [Fig. p. 5 : la demande d'Arlequin ]. [Cote : microfilm R 26976] ; [Pl. en reg. p.7 :] Quantumque la chaine et la Medaglia Pour la monstrer à ces Messieurs d'Itaglia. [Cote : microfilm R 26976] ; [Pl. p. 48 :] A Dieu mon Roy et Reine et mes Amis Pour vous obeyr je m'en vay à Paris. [Cote : microfilm R 26976] ; [Pl. p. 50 :] Fradeli à menenuo con Arlechin A guadagnar un poco di quatrin. [Cote : microfilm R 26976] ; [Pl. p. 51 :] Vammo à Paris à fé da Cavagler Que gannaremo aglia bien da comer. [Cote : microfilm R 26976]

Po. Hordones de Zeballos

Donateur : Romanet Du Caillaud, Frédéric (18..-19..?)

Guide to Scholarships and Grants

2015-16 publication highlighting Iowa Scholarships and Grants administered by the Iowa College Student Aid Commission.

In vivo and in vitro development of alpha-MSH and ACTH in the embryonic and postnatal rat brain.

The appearance of immunoreactive alpha-melanotropin (alpha-MSH) and adrenocorticotropin (ACTH) during development was studied in 3 areas of the rat brain--cerebral hemispheres, midbrain and hindbrain--from embryonic day (ED) 13-14 until day 21 postnatally. The alpha-MSH content in vivo was always highest in the midbrain; a peak content at birth was followed by a transient decline and a later, higher plateau from postnatal day 7 onwards. The alpha-MSH content in the cerebral hemispheres rose progressively after birth reaching a peak at day 21. Values in the hindbrain rose at day 3 and changed relatively sue taken at ED 15-16 showed a gradual increase in alpha-MSH content over the 20 days. The alpha-MSH content of hindbrain cultures remained at constant low levels, while no alpha-MSH was detectable in cerebral hemisphere cultures. ACTH appeared in vivo earlier than alpha-MSH and was detectable in embryonic brains at ED 13-14. A transient rise was seen at ED 17-18 and major peaks at birth, day 2 and day 3, in the midbrain, hemispheres and hindbrain, respectively. In vitro, the ACTH content increased in all brain regions during the first 5 days in culture and showed no further change thereafter. Comparisons of the in vivo and in vitro development of alpha-MSH and ACTH demonstrate that (i) these two peptide systems are independent in respect to their localization and time of appearance; (ii) they undergo maturation both in vivo and in vitro; (iii) epigenetic factors, such as interactions with other neurotransmitter systems may modulate the developmental pattern of these two peptides.

Desempenho de clones de copa de seringueira resistentes ao mal-das-folhas

O objetivo deste trabalho foi avaliar o desempenho de 18 clones de seringueira resistentes ao Microcyclus ulei, usados como copas enxertadas. Foram utilizados oito clones híbridos de Hevea pauciflora x Hevea guianensis var. marginata, oito de H. pauciflora x H. rigidifolia e dois clones de H. pauciflora, enxertados sobre o painel de CNS AM 7905 - seleção primária de H. brasiliensis - e cultivados em Latossolo Amarelo distrófico, em Manaus, AM. Foram avaliados: perímetro do tronco, estado nutricional e produtividade de borracha seca. Copas enxertadas de híbridos H. pauciflora x H. guianensis var. marginata causam crescimento mais rápido do tronco, com redução do período de imaturidade da seringueira. O alto nível de resistência dos híbridos de H. rigidifolia ao percevejo-de-renda (Leptopharsa heveae) justifica a introdução de outros genótipos dessa espécie para novas hibridações. Os clones CPAA C 01, 06, 13, 15, 16 e 45 apresentam excelente potencial de produção de borracha seca, nas condições climáticas e de solos de terra firme da Amazônia Tropical Úmida.

Type of alcoholic beverage and risk of head and neck cancer: a pooled analysis within the INHANCE Consortium

The authors pooled data from 15 case-control studies of head and neck cancer (9,107 cases, 14,219 controls) to investigate the independent associations with consumption of beer, wine, and liquor. In particular, they calculated associations with different measures of beverage consumption separately for subjects who drank beer only (858 cases, 986 controls), for liquor-only drinkers (499 cases, 527 controls), and for wine-only drinkers (1,021 cases, 2,460 controls), with alcohol never drinkers (1,124 cases, 3,487 controls) used as a common reference group. The authors observed similar associations with ethanol-standardized consumption frequency for beer-only drinkers (odds ratios (ORs) = 1.6, 1.9, 2.2, and 5.4 for < or =5, 6-15, 16-30, and >30 drinks per week, respectively; P(trend) < 0.0001) and liquor-only drinkers (ORs = 1.6, 1.5, 2.3, and 3.6; P < 0.0001). Among wine-only drinkers, the odds ratios for moderate levels of consumption frequency approached the null, whereas those for higher consumption levels were comparable to those of drinkers of other beverage types (ORs = 1.1, 1.2, 1.9, and 6.3; P < 0.0001). Study findings suggest that the relative risks of head and neck cancer for beer and liquor are comparable. The authors observed weaker associations with moderate wine consumption, although they cannot rule out confounding from diet and other lifestyle factors as an explanation for this finding. Given the presence of heterogeneity in study-specific results, their findings should be interpreted with caution.